p.126 抽出テキスト

先天性心疾患,心臓大血管の構造的疾患(structural heart disease) に対するカテーテル治療のガイドライン

37. Leon MB, Smith CR, Mack M, et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607. PMID: 20961243 38. Smith CR, Leon MB, Mack MJ, et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198. PMID: 21639811 39. Yamamoto M, Watanabe Y, Tada N, et al. OCEAN-TAVI investigators. Transcatheter aortic valve replacement outcomes in Japan: Optimized CathEter vAlvular iNtervention (OCEAN) Japanese multicenter registry. Cardiovasc Revasc Med 2019; 20: 843-851. PMID: 30553819 40. Wiedemann D, Mahr S, Vadehra A, et al. Thoracic endovascular aortic repair in 300 patients: long-term results. Ann Thorac Surg 2013; 95: 1577-1583. PMID: 23566647 41. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. Cholesterol Embolism Study(CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42: 211-216. PMID: 12875753 42. Leurs LJ, Bell R, Degrieck Y, et al. Endovascular treatment of thoracic aortic diseases: combined experience from the EUROSTAR and United Kingdom Thoracic Endograft registries. J Vasc Surg 2004; 40: 670-679. PMID: 15472593 43. Fairman RM, Tuchek JM, Lee WA, et al. VALOR II Investigators,. Pivotal results for the Medtronic Valiant Thoracic Stent Graft System in the VALOR II trial. J Vasc Surg 2012; 56: 1222-1231. PMID: 22832267 44. IVR等に伴う放射線皮膚障害とその防護対策検討会.IVR伴う放射線皮膚障害の防止に関するガイドライン.http://www.jsir.or.jp/ wp-content/uploads/2015/03/ivr_hifusyogai_GL.pdf 45. Kodzwa R. ACR Manual on Contrast Media: 2018 Updates. Radiol Technol 2019; 91: 97-100. PMID: 31471485 46. Silvestry FE, Kerber RE, Brook MM, et al. Echocardiography-guided interventions. J Am Soc Echocardiogr 2009; 22: 213-231. PMID: 19258174 47. Zamorano JL, Gonçalves A, Lang R. Imaging to select and guide transcatheter aortic valve implantation. Eur Heart J 2014; 35: 1578- 1587. PMID: 24459198 48. Akaishi M, Asanuma T, Izumi C, et al. Guidelines for conducting transesophageal echocardiography (TEE) : Task force for guidelines for conducting TEE: November 15, 2015. J Echocardiogr 2016; 14: 47-48. PMID: 26894387 49. Hahn RT, Abraham T, Adams MS, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2013; 26: 921-964. PMID: 23998692 50. Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J 2011; 32: 2189-2214. PMID: 21885465 51. Suchon E, Pieculewicz M, Tracz W, et al. Transcatheter closure as an alternative and equivalent method to the surgical treatment of atrial septal defect in adults: comparison of early and late results. Med Sci Monit 2009; 15: CR612-617. PMID: 19946231 52. Kaya MG, Baykan A, Dogan A, et al. Intermediate-term effects of transcatheter secundum atrial septal defect closure on cardiac remodeling in children and adults. Pediatr Cardiol 2010; 31: 474-482. PMID: 20084376 53. 日本循環器学会.成人先天性心疾患診療ガイドライン(2017年改訂版).https://www.j-circ.or.jp/old/guideline/pdf/JCS2017_ichida_h.pdf 54. Mills NL, King TD. Nonoperative closure of left-to-right shunts. J Thorac Cardiovasc Surg 1976; 72: 371-378. PMID: 134183 55. Mills NL, King TD. Late follow-up of nonoperative closure of secundum atrial septal defects using the King-Mills double-umbrella device. Am J Cardiol 2003; 92: 353-355. PMID: 12888154 56. Masura J, Gavora P, Formanek A, et al. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997; 42: 388-393. PMID: 9408617 57. 日本先天性心疾患インターベンション学会(JCIC).カテーテル治療について.http://www.jpic-meeting.org/cathe/ 58. Kijima Y, Akagi T, Takaya Y, et al. Deficient Surrounding Rims in Patients Undergoing Transcatheter Atrial Septal Defect Closure. J Am Soc Echocardiogr 2016; 29: 768-776. PMID: 27236281 59. Moore J, Hegde S, El-Said H, et al. ACC IMPACT Steering Committee. Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv 2013; 6: 433-442. PMID: 23702008 60. McElhinney DB, Quartermain MD, Kenny D, et al. Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case-Control Study. Circulation 2016; 133: 1738-1746. PMID: 27002094 61. Amin Z. Echocardiographic predictors of cardiac erosion after Am-

platzer septal occluder placement. Catheter Cardiovasc Interv 2014; 83: 84-92. PMID: 24038861 62. Kijima Y, Akagi T, Nakagawa K, et al. Cardiac erosion after catheter closure of atrial septal defect: Septal malalignment may be a novel risk factor for erosion. J Cardiol Cases 2014; 9: 134-137. PMID: 30546783 63. Knepp MD, Rocchini AP, Lloyd TR, et al. Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder. Congenit Heart Dis 2010; 5: 32-37. PMID: 20136855 64. Kodaira M, Kawamura A, Okamoto K, et al. Comparison of Clinical Outcomes After Transcatheter vs. Minimally Invasive Cardiac Surgery Closure for Atrial Septal Defect. Circ J 2017; 81: 543-551. PMID: 28154290 65. Turner DR, Owada CY, Sang CJ Jr, et al. Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study. Circ Cardiovasc Interv 2017; 10: e004212. PMID: 28801537 66. Haas NA, Soetemann DB, Ates I, et al. Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series. Catheter Cardiovasc Interv 2016; 88: 571-581. PMID: 27029396 67. Kenny D, Eicken A, Dähnert I, et al. Investigators. A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv 2019; 93: 316-321. PMID: 30719850 68. Roymanee S, Promphan W, Tonklang N, et al. Comparison of the Occlutech® Figulla® septal occluder and Amplatzer® septal occluder for atrial septal defect device closure. Pediatr Cardiol 2015; 36: 935- 941. PMID: 25633819 69. DiBardino DJ, McElhinney DB, Kaza AK, et al. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 2009; 137: 1334-1341. PMID: 19464444 70. Du ZD, Hijazi ZM, Kleinman CS, et al. Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002; 39: 1836-1844. PMID: 12039500 71. El-Said HG, Moore JW. Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations? Catheter Cardiovasc Interv 2009; 73: 925-930. PMID: 19455668 72. Levi DS, Moore JW. Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 2004; 61: 543-547. PMID: 15065154 73. Everett AD, Jennings J, Sibinga E, et al. Community use of the amplatzer atrial septal defect occluder: results of the multicenter MAG- IC atrial septal defect study. Pediatr Cardiol 2009; 30: 240-247. PMID: 19015911 74. deleted in proof 75. Amin Z, Hijazi ZM, Bass JL, et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63: 496-502. PMID: 15558755 76. Kitano M, Yazaki S, Sugiyama H, et al. Risk Factors and Predictors of Cardiac Erosion Discovered from 12 Japanese Patients Who Developed Erosion After Atrial Septal Defect Closure Using Amplatzer Septal Occluder. Pediatr Cardiol 2020; 41: 297-308. PMID: 31732763 77. Abe T, Tsukano S, Tosaka Y. Pericardial tamponade due to erosion of a Figulla Flex II device after closure of an atrial septal defect. Catheter Cardiovasc Interv 2019; 94: 1003-1005. PMID: 31194277 78. Auriau J, Bouvaist H, Aaberge L, et al. Cardiac Erosions After Transcatheter Atrial Septal Defect Closure With the Occlutech Figulla Flex Device. JACC Cardiovasc Interv 2019; 12: 1397-1399. PMID: 31320034 79. Ha KS, Choi JY, Jung SY, et al. A novel double snare technique to retrieve embolized septal and left atrial appendage occluders. J Interv Cardiol 2018; 31: 685-692. PMID: 29696697 80. Akagi T. Current concept of transcatheter closure of atrial septal defect in adults. J Cardiol 2015; 65: 17-25. PMID: 25308548 81. Campbell M. Natural history of atrial septal defect. Br Heart J 1970;